Posttranslational Modifications of Red Blood Cell Ghost Proteins as “Signatures” for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients

Ítems similars

• Posttranslational Modifications of Red Blood Cell Ghost Proteins as 'Signatures' for Distinguishing between Low- and High-Risk Myelodysplastic Syndrome Patients
  per: Klara Pecankova, et al.
  Publicat: (2017-03-01)
• Peripheral Blood Mononuclear Cell Proteome Changes in Patients with Myelodysplastic Syndrome
  per: Pecankova, Klara, et al.
  Publicat: (2015)
• Plasma Protein Biomarker Candidates for Myelodysplastic Syndrome Subgroups
  per: Majek, Pavel, et al.
  Publicat: (2015)
• Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2
  per: Majek, Pavel, et al.
  Publicat: (2014)
• Plasma proteome changes associated with refractory anemia and refractory anemia with ringed sideroblasts in patients with myelodysplastic syndrome
  per: Májek, Pavel, et al.
  Publicat: (2013)